Skip to main content
. 2022 Nov 4;50(3):859–869. doi: 10.1007/s00259-022-06006-1

Table 2.

Treatment regimens in patients with lower or higher than median SUVmax

SUVmax ≤ median (n; %) SUVmax > median (n; %) p-value

IDH-wildtype (n = 42)

Radio-and chemotherapy

Radiotherapy only

Chemotherapy only

Experimental/others

No tumor-specific therapy

21 (100)

7 (33.3)

7 (33.3)

4 (19.0)

0 (0.0)

3 (14.3)

21 (100)

5 (23.8)

8 (38.1)

6 (28.6)

2 (9.5)

0 (0.0)

0.215

IDH-mutant (n = 46)

Radio-and chemotherapy

Radiotherapy only

Chemotherapy only

Experimental/others

23 (100)

7 (30.4)

12 (52.2)

4 (17.4)

0 (0.0)

23 (100)

7 (30.4)

7 (30.4)

8 (34.8)

1 (4.3)

0.302

SUVmax maximum standardized uptake value, IDH isocitrate dehydrogenase